	US 11,806,340 B2
	Methods of diagnosing and treating conduct disorder
Hakon Hakonarson, Malvern, PA (US); and Charlly Kao, Philadelphia, PA (US)
Assigned to THE CHILDREN'S HOSPITAL OF PHILADELPHIA, Philadelphia, PA (US)
Filed by THE CHILDREN'S HOSPITAL OF PHILADELPHIA, Philadelphia, PA (US)
Filed on Oct. 27, 2021, as Appl. No. 17/511,795.
Application 17/511,795 is a continuation of application No. 15/258,969, filed on Sep. 7, 2016, granted, now 11,179,378.
Claims priority of provisional application 62/215,673, filed on Sep. 8, 2015.
Claims priority of provisional application 62/215,636, filed on Sep. 8, 2015.
Claims priority of provisional application 62/215,628, filed on Sep. 8, 2015.
Claims priority of provisional application 62/215,633, filed on Sep. 8, 2015.
Prior Publication US 2022/0117953 A1, Apr. 21, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/454 (2006.01); A61K 45/06 (2006.01); C12Q 1/6883 (2018.01)

CPC A61K 31/454 (2013.01) [A61K 45/06 (2013.01); C12Q 1/6883 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/158 (2013.01)]

18 Claims

1. A method of treating conduct disorder in a subject, comprising administering an effective amount of fasoracetam to the subject, wherein fasoracetam is administered at a dose of 50-400 mg, 100-400 mg, or 200-400 mg, and wherein the dose is administered once, twice, or three times daily.